Physician profile
Burton L Redd
NPI 1437269206
$423,190.04
in general payments reported to CMS, 2019-2025
16 companies · $68K in 2025
The $68K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52K · 2020: $59K · 2021: $55K · 2022: $63K · 2023: $66K · 2024: $61K · 2025: $68K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $195K · Food and Beverage: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $194,500.00 |
| Food and Beverage | $166.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sequoia Surgical Distributors, LLC | $422,000.00 | 2019-2025 | |
| Djo, LLC | $303.50 | 2019 | |
| Pacira Therapeutics, INC. | $194.48 | 2019-2021 | |
| Skeletal Dynamics INC | $175.00 | 2019 | |
| Medical Device Business Services, INC. | $129.55 | 2024 | Vistaseal |
| Smith+Nephew, INC. | $120.86 | 2019-2021 | |
| Pfizer INC. | $54.94 | 2019-2021 | |
| Heron Therapeutics, INC. | $49.61 | 2019 | |
| Ethicon US, LLC | $36.81 | 2024 | Surgicel Nu-Knit, Ethicon, Vistaseal |
| Ferring Pharmaceuticals INC. | $29.04 | 2019 | |
| Endo Pharmaceuticals INC. | $24.64 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $20.56 | 2019 | |
| Melinta Therapeutics, LLC | $15.14 | 2019 | |
| Vericel Corporation | $13.66 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $11.61 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $10.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$111,180.96 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Burton Redd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.